Literature DB >> 27400127

Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy.

Khalil Miloudi, François Binet, Ariel Wilson, Agustin Cerani, Malika Oubaha, Catherine Menard, Sullivan Henriques, Gaelle Mawambo, Agnieszka Dejda, Phuong Trang Nguyen, Flavio A Rezende, Steve Bourgault, Timothy E Kennedy, Przemyslaw Sapieha.   

Abstract

Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness in the working-age population. Impaired blood-retinal barrier function leads to macular edema that is closely associated with the deterioration of central vision. We previously demonstrated that the neuronal guidance cue netrin-1 activates a program of reparative angiogenesis in microglia within the ischemic retina. Here, we provide evidence in both vitreous humor of diabetic patients and in retina of a murine model of diabetes that netrin-1 is metabolized into a bioactive fragment corresponding to domains VI and V of the full-length molecule. In contrast to the protective effects of full-length netrin-1 on retinal microvasculature, the VI-V fragment promoted vascular permeability through the uncoordinated 5B (UNC5B) receptor. The collagenase matrix metalloprotease 9 (MMP-9), which is increased in patients with diabetic macular edema, was capable of cleaving netrin-1 into the VI-V fragment. Thus, MMP-9 may release netrin-1 fragments from the extracellular matrix and facilitate diffusion. Nonspecific inhibition of collagenases or selective inhibition of MMP-9 decreased pathological vascular permeability in a murine model of diabetic retinal edema. This study reveals that netrin-1 degradation products are capable of modulating vascular permeability, suggesting that these fragments are of potential therapeutic interest for the treatment of DR.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27400127      PMCID: PMC4966311          DOI: 10.1172/JCI84767

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

1.  Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development.

Authors:  G S Robinson; M Ju; S C Shih; X Xu; G McMahon; R B Caldwell; L E Smith
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

Review 2.  Netrins: versatile extracellular cues with diverse functions.

Authors:  Karen Lai Wing Sun; James P Correia; Timothy E Kennedy
Journal:  Development       Date:  2011-06       Impact factor: 6.868

3.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.

Authors:  R H Adams; G A Wilkinson; C Weiss; F Diella; N W Gale; U Deutsch; W Risau; R Klein
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

4.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

5.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

6.  Role of the neuropilin ligands VEGF164 and SEMA3A in neuronal and vascular patterning in the mouse.

Authors:  Joaquim Miguel Vieira; Quenten Schwarz; Christiana Ruhrberg
Journal:  Novartis Found Symp       Date:  2007

7.  Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.

Authors:  Juan E Grunwald; Ebenezer Daniel; Jiayan Huang; Gui-Shuang Ying; Maureen G Maguire; Cynthia A Toth; Glenn J Jaffe; Stuart L Fine; Barbara Blodi; Michael L Klein; Alison A Martin; Stephanie A Hagstrom; Daniel F Martin
Journal:  Ophthalmology       Date:  2013-09-29       Impact factor: 12.079

8.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

9.  Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.

Authors:  Sunyoung Lee; Shahla M Jilani; Ganka V Nikolova; Darren Carpizo; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2005-05-23       Impact factor: 10.539

10.  Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors.

Authors:  Magali Saint-Geniez; Arindel S R Maharaj; Tony E Walshe; Budd A Tucker; Eiichi Sekiyama; Tomoki Kurihara; Diane C Darland; Michael J Young; Patricia A D'Amore
Journal:  PLoS One       Date:  2008-11-03       Impact factor: 3.240

View more
  11 in total

1.  A Developmental Program Truncates Long Transcripts to Temporally Regulate Cell Signaling.

Authors:  Jeremy E Sandler; Jihyun Irizarry; Vincent Stepanik; Leslie Dunipace; Henry Amrhein; Angelike Stathopoulos
Journal:  Dev Cell       Date:  2018-12-17       Impact factor: 12.270

2.  Solution Structure of C. elegans UNC-6: A Nematode Paralogue of the Axon Guidance Protein Netrin-1.

Authors:  Natalie Krahn; Markus Meier; Raphael Reuten; Manuel Koch; Joerg Stetefeld; Trushar R Patel
Journal:  Biophys J       Date:  2019-05-03       Impact factor: 4.033

3.  Comprehensive analysis of mouse retinal mononuclear phagocytes.

Authors:  Anika Lückoff; Rebecca Scholz; Florian Sennlaub; Heping Xu; Thomas Langmann
Journal:  Nat Protoc       Date:  2017-05-04       Impact factor: 13.491

Review 4.  Targeting Netrin-1 and -4 as a Novel Diagnostic Parameter and Treatment Option for Diabetic Retinopathy.

Authors:  Kaleab Alemayehu Zewdie; Muluken Altaye Ayza; Bekalu Amare Tesfaye; Ebrahim M Yimer
Journal:  Clin Ophthalmol       Date:  2020-06-25

5.  Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?

Authors:  Murat Okutucu; Hüseyin Fındık; Mehmet Gökhan Aslan; Medeni Arpa
Journal:  BMC Ophthalmol       Date:  2021-05-31       Impact factor: 2.209

6.  Melanocortin receptor agonists MCR1-5 protect photoreceptors from high-glucose damage and restore antioxidant enzymes in primary retinal cell culture.

Authors:  Rosa Maisto; Carlo Gesualdo; Maria Consiglia Trotta; Paolo Grieco; Francesco Testa; Francesca Simonelli; Jorge Miquel Barcia; Michele D'Amico; Clara Di Filippo; Settimio Rossi
Journal:  J Cell Mol Med       Date:  2016-12-20       Impact factor: 5.310

Review 7.  Netrin as a Novel Biomarker and Its Therapeutic Implications in Diabetes Mellitus and Diabetes-Associated Complications.

Authors:  Ebrahim M Yimer; Kaleab Alemayehu Zewdie; Hailemichael Zeru Hishe
Journal:  J Diabetes Res       Date:  2018-09-18       Impact factor: 4.011

8.  Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study.

Authors:  David J Valent; Wai T Wong; Emily Y Chew; Catherine A Cukras
Journal:  Transl Vis Sci Technol       Date:  2018-12-17       Impact factor: 3.283

9.  Silencing Myeloid Netrin-1 Induces Inflammation Resolution and Plaque Regression.

Authors:  Martin Schlegel; Monika Sharma; Emily J Brown; Alexandra A C Newman; Yannick Cyr; Milessa Silva Afonso; Emma M Corr; Graeme J Koelwyn; Coen van Solingen; Jonathan Guzman; Rubab Farhat; Cyrus A Nikain; Lianne C Shanley; Daniel Peled; Ann Marie Schmidt; Edward A Fisher; Kathryn J Moore
Journal:  Circ Res       Date:  2021-07-22       Impact factor: 23.213

10.  Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy.

Authors:  Jie-Hong Wu; Ya-Nan Li; An-Qi Chen; Can-Dong Hong; Chun-Lin Zhang; Hai-Ling Wang; Yi-Fan Zhou; Peng-Cheng Li; Yong Wang; Ling Mao; Yuan-Peng Xia; Quan-Wei He; Hui-Juan Jin; Zhen-Yu Yue; Bo Hu
Journal:  EMBO Mol Med       Date:  2020-01-13       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.